HealthcareServices

Orthobiologics Market Forecast 2025–2034: Where Businesses Should Invest Next

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Orthobiologics Market Between 2025 And 2029?

The orthobiologics market has demonstrated robust expansion over recent years. Its valuation is anticipated to climb from $7.08 billion in 2024 to $7.48 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.7%. This past growth can be attributed to the escalating prevalence of orthopedic diseases and conditions, a progression towards minimally invasive procedures, an increase in reconstructive surgeries, heightened healthcare expenditure, improved awareness among patients and healthcare providers, and economic advancement in emerging markets.

The orthobiologics market size is anticipated to see significant growth in the upcoming years, with projections indicating it will grow to $9.39 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. This expansion during the forecast period is attributed to factors like the aging population and sedentary lifestyles, ongoing development of advanced products, favorable reimbursement policies, regulatory approvals for new orthobiologic products, and expanded indications for existing orthobiologic products. Key trends expected in the forecast period include advancements in regenerative medicine, product innovations, technological advancements, strategic initiatives, and market expansion.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp

What Are The Top Growth Drivers Impacting The Orthobiologics Market Outlook?

The orthobiologics market is anticipated to expand due to the rising incidence of road accidents and sports injuries. These incidents involve physical harm to individuals, frequently affecting the musculoskeletal system. Factors contributing to road accidents include distracted driving, speeding, and inadequate road conditions, while sports injuries stem from overuse, incorrect equipment, and insufficient training. Orthobiologics offer therapeutic benefits for such injuries by facilitating quicker and more efficient healing of musculoskeletal tissues, decreasing inflammation, and augmenting the body’s inherent repair mechanisms, utilizing materials like bone grafts, growth factors, stem cells, and platelet-rich plasma. A relevant example is from March 2024, where Eurostat, a Europe-based statistical office of the European Union, reported that road accidents claimed 20653 lives in Europe in 2022, representing a 3.7% increase from 19917 fatalities in 2021. Consequently, the growing occurrence of sports injuries and road accidents is set to stimulate the orthobiologics market.

What Are The Major Segment Types Covered In The Orthobiologics Market?

The orthobiologicsmarket covered in this report is segmented –

1) By Product Type: Viscosupplements; Bone Growth Factors; Demineralized Bone Matrix; Synthetic Bone Substitutes; Cellular Allograft; Other Products

2) By Application: Spinal Fusion; Maxillofacial And Dental; Soft Tissue Repair; Reconstructive And Fracture Surgery; Other Applications

3) By End User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End Users

Subsegments:

1) By Viscosupplements: Hyaluronic Acid Injections; Gel-Based Viscosupplements; Cross-linked Hyaluronic Acid; Other Viscosupplement Products

2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs); Recombinant Human Bone Morphogenetic Proteins (rhBMPs); Platelet-Rich Plasma (PRP); Osteogenic Protein-1 (OP-1); Growth Factors For Bone Healing

3) By Demineralized Bone Matrix: DBM Grafts; DBM Putty; DBM Sponges; DBM Paste And Chips

4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes; Calcium Sulfate-Based Substitutes; Tricalcium Phosphate (TCP); Hydroxyapatite (HA); Bioactive Glasses; Other Synthetic Bone Substitutes

5) By Cellular Allograft: Osteocellular Allografts; Mesenchymal Stem Cells (MSCs) Allografts; Bone Marrow-Derived Cellular Allografts; Adipose Tissue-Derived Cellular Allografts

6) By Other Products: Autografts; Collagen-Based Grafts; Synthetic Bone Graft Substitutes (Non-Bioactive); Amniotic Membrane-Based Grafts; Exosome-Based Products; Other Miscellaneous Orthobiologic Products

Which Competitive Trends Are Defining The Orthobiologics Market Structure?

Major companies in the orthobiologics market are developing advanced solutions, such as dry allograft mixtures, to improve bone healing and fusion during orthopedic procedures. These dry allograft mixtures integrate robust cortical fibers with mineralized cortical bone, offering structural support and promoting osteoinductive properties that facilitate new bone formation. For instance, in May 2024, Isto Biologics, a US-based biologics-focused company, launched Fibrant Liberty allograft, a dry allograft mixture that combines robust cortical fibers with mineralized cortical cancellous chips. Upon hydration, the graft becomes pliable and can be customized for various surgical procedures. The longer and stronger fibers enhance handling and create an intricate network that prevents graft migration while maintaining structural integrity.

Which Key Market Players Are Investing In Expansion And Innovation Of Orthobiologics Market?

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

How Do Regional Market Performances Compare Within The Orthobiologics Industry?

North America was the largest region in the orthobiologics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Orthobiologics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16139&type=smp

Browse Through More Reports Similar to the Global Orthobiologics Market 2025, By The Business Research Company

Oral Biologics And Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

Biologics Contract Development Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Biologics Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795